Focus on Lipids Care

Back to articles

Alternatives for patients with muscle-related statin intolerance

KEY POINT

Use of evolocumab (Repatha—Amgen) resulted in greater reductions in LDL levels compared with ezetimibe (Zetia—Merck) and was well tolerated in patients with elevated LDL levels and a history of muscle-related statin intolerance, according to results of the GAUSS-3 trial published in JAMA.